Cure Leukaemia
Charity 1100154
Overview
Summary
Cure Leukaemia appears to operate primarily as a research-and-access charity rather than a direct care provider. Its role is to mobilise public, patient and corporate support around clinical-trial networks, using fundraising and patient storytelling to help connect adults and children with blood cancer to experimental or cutting-edge treatments. The available evidence suggests a national or international-facing ambition, while its operating model depends on relationships with hospitals, researchers, fundraisers and partner organisations.
Operational geography
Evidence and reasoning
Supporting evidence
Edgbaston
Confidence: high
Direct evidence shows Cure Leukaemia currently funds a clinical research nurse and clinical-trial access at Queen Elizabeth Hospital Birmingham. The hospital's official address identifies it as being in Edgbaston. This is an operational delivery location through a materially funded NHS partner, rather than evidence of a Cure Leukaemia-owned site.
- Cure Leukaemia, "Supporting Patients In Birmingham"
The charity states that, at Queen Elizabeth Hospital, it funds a dedicated clinical research nurse to enable patient access to treatments and clinical trials. - NHS, Queen Elizabeth Hospital Birmingham contact information
The hospital address is Mindelsohn Way, Edgbaston, Birmingham, B15 2WB.
City Centre
Confidence: medium
Direct evidence establishes current Cure Leukaemia support through Birmingham Children's Hospital as part of the ATICUS Network. The hospital is on Steelhouse Lane in Birmingham city centre; assigning the supplied City Centre place identifier is a reasonable geographic interpretation rather than a location label used by Cure Leukaemia itself.
- Cure Leukaemia, "Supporting Patients In Birmingham"
The charity states that Birmingham Children's Hospital is an important part of its ATICUS Network, supporting research opportunities for young blood-cancer patients and their families. - Birmingham Women's and Children's NHS Foundation Trust, "Getting here"
The trust gives Birmingham Children's Hospital's address as Steelhouse Lane, Birmingham, B4 6NH, and directs visitors to Birmingham City Centre local-area maps.
Remaining uncertainties
- The evidence confirms delivery through Queen Elizabeth Hospital Birmingham and Birmingham Children's Hospital, but does not identify all Birmingham sites at which Cure Leukaemia-funded trials, research staff or network activity may currently operate.
- The charity's registered address is in Edgbaston and its website gives a Solihull PO Box, but neither source establishes either as a staffed Cure Leukaemia operational site; they have therefore not been treated as physical delivery sites.
- Cure Leukaemia describes its work as supporting patients across Birmingham and the region, but the available evidence does not demonstrate routine operational delivery in every Birmingham ward. Its Birmingham footprint is better evidenced as hospital-centred than neighbourhood-based.
- The website refers to global or worldwide impact, but the current evidence of identifiable service and trial-network locations is principally across the UK. This supports a national classification rather than an international one.
Additional evidence needed
- A current Cure Leukaemia-funded site roster or grant schedule identifying every Birmingham hospital, clinic and research post supported.
- A current annual or impact report specifying the geography and active status of the Trials Acceleration Programme, ATICUS Network and other funded networks.
- Confirmation from Cure Leukaemia of any staffed Birmingham office or other physical premises that it operates directly.
Areas of work
- The Advancement Of Health Or Saving Of Lives
Who they help
- Other Defined Groups
- The General Public/mankind
How they help
- Makes Grants To Organisations
- Provides Advocacy/advice/information
- Provides Human Resources
- Sponsors Or Undertakes Research
Discoveries involving this organisation
The Atlas has not published any Discoveries involving this organisation yet.
Findings
A connector between fundraising and clinical-trial access
Cure Leukaemia appears to translate charitable income into capacity for research networks and clinical trials, rather than presenting itself chiefly as a provider of frontline patient services.
Why it matters
This clarifies the organisation's likely place in the blood-cancer system: its value may lie in enabling treatment innovation and access through institutional partners, rather than in replacing NHS clinical care.
Show evidence
“Cure Leukaemia funds world-leading networks that help adults and children access cutting-edge treatments through clinical trials.”
Source:Organisation“The charity makes grants to organisations, provides human resources, provides advocacy/advice/information, and sponsors or undertakes research.”
Source:Charity Commission
Patient stories function as part of its mobilisation model
The organisation appears to use lived experience not only for awareness, but to connect blood cancer with fundraising, public support and the case for research investment.
Why it matters
This suggests that patients and families are important relationship-builders within the charity's model, helping make a complex research agenda understandable and actionable to supporters.
Show evidence
“The website features patient stories including Adam's, Harry's and Kathryn's.”
Source:Organisation“The website invites people to fundraise, donate, partner as an organisation and claim a Cure Leukaemia pin badge.”
Source:Organisation
Its collaboration strategy may extend beyond the health sector
Cure Leukaemia appears to build support through sports, community fundraising and corporate partnerships, creating routes into blood-cancer research for people and organisations not otherwise connected to specialist medicine.
Why it matters
This indicates a potentially broad civic network: partnership opportunities may be as important to the charity's capacity as relationships with clinical and research institutions.
Show evidence
“The website reports a partnership with Engage Wealth Management.”
Source:Organisation“The website reports fundraising through TourDe4 and community fundraising by families in Worcestershire.”
Source:Organisation
- Which clinical-trial networks, hospitals and research institutions receive support, and how funding is allocated between them.
- Whether the charity provides direct practical support to patients, or primarily signposts them to information and trial opportunities.
- How far its stated global ambition is reflected in activity outside the UK.
Remaining uncertainties
- Annual reports or accounts showing grant recipients, research expenditure, staffing and fundraising income.
- Details of clinical partners, trial outcomes, patient reach and the charity's role in referral or recruitment pathways.